Myo-inositol + Selenium

Treatment for Hashimoto's Thyroiditis

Typical Dosage: Myo-inositol 600mg + Selenium 83-200 mcg daily

Effectiveness
55%
Safety Score
88%
Clinical Trials
1
Participants
1.5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
88
DangerousModerateSafe
Treatment Details
Dosage Range
Myo-inositol 600mg + Selenium 83-200 mcg daily
Time to Effect
3-6 months
Treatment Duration
6-12 months, then re-evaluate
Evidence Quality
LOW
Confidence Score
60%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$70
Monitoring:$50
Side Effect Mgmt:$10
Total Annual:$130
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POOR
QALYs Gained
0.08
Outcome-Based Costs
Cost per Responder
$260
Comparison vs No supplementation
Cost Difference
+$130/year
More expensive
QALY Difference
+0.05 QALYs
Better outcomes
Dominance
No dominance
Myo-inositol + Selenium Outcomes

for Hashimoto's Thyroiditis

Efficacy Outcomes
Overall Effectiveness
+55%
Response Rate
+50%
Common Side Effects
Mild GI upset (Myo-inositol)
+8%
Selenium toxicity (rare, with excessive dosing)
+0.1%

Sources:

palomahealth.com
jst.go.jp
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Myo-inositol + Selenium in Hashimoto's Thyroiditis

A Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients With Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism

NCT06867913COMPLETEDNA
View Study
40 participants
INTERVENTIONAL
Novosibirsk, Russia
Started: May 15, 2024